IDH1 and cancer: In cancer cells, IDH1/2 mutations lead to excessive accumulation of 2-HG, which is an oncometabolite inducing biochemical and epigenetic alterations though competitive inhibition of a-KG-dependent enzymes including KDMs, PHDs, TETs, and ALKBH DNA repairs enzymes [167].